查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1446412

腸溶軟膠囊市場：按應用、按分銷管道：2023-2032 年全球機會分析和產業預測

Enteric Softgel Capsules Market By Application (Health Supplements, Pharmaceuticals), By Distribution Channel (Supermarket and Hypermarket, Pharmacy and Drug store, Online Provider): Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 250 Pages | 商品交期: 2-3個工作天內

價格
腸溶軟膠囊市場-IMG1

補充品的快速採用營養補充腸溶軟膠囊的相關食品有力地推動了腸溶軟膠囊市場的成長。隨著健康意識的提高，營養補充的需求食品增加，促進營養補充食品的穩定擴張。腸溶衣軟膠囊以其精確客製化的腸溶衣而著稱，已成為一種戰略解決方案，可提供精緻的活性成分，同時保護它們免受胃部嚴酷酸性條件的影響。這種標靶釋放機制可最佳化腸道吸收並提高藥物和營養素的生物有效性。腸溶衣軟膠囊適合精緻的配方，使其成為旨在有效且高效地提供促進健康的化合物的製造商的首選。

此外，腸溶軟膠囊的好處還包括提高患者的依從性，有效減少胃腸道不適的發生。減少副作用的能力提高了補充品和藥物的整體耐受性，並促進持續使用。此外，腸溶軟膠囊適用於多種配方，使其在製藥和營養補充食品中更受歡迎。不斷擴大的營養補充食品和腸溶軟膠囊的獨特優勢將無縫協同效應，推動市場成長，而這種成長是由注重健康的消費者不斷變化的偏好所驅動，尋求高效且耐受性良好的健康解決方案。它反映了成長。

相關人員的主要利益

  • 該報告提供了細分市場、當前趨勢、估計和動態的定量分析，以及 2022 年至 2032 年腸溶衣軟膠囊市場分析的動態，並確定了腸溶衣軟膠囊市場有前景的市場機會。
  • 我們提供市場研究以及與市場促進因素、市場限制和市場機會相關的資訊。
  • 波特的五力分析強調買家和供應商幫助相關人員做出利潤驅動的商業決策並加強供應商-買家網路的潛力。
  • 腸溶軟膠囊市場區隔的詳細分析有助於識別市場機會。
  • 每個地區的主要國家都根據其對全球市場的收益貢獻繪製了地圖。
  • 市場公司定位有助於基準化分析並提供對市場公司當前地位的清晰了解。
  • 該報告包括區域和全球腸溶軟膠囊市場趨勢、主要企業、細分市場、應用領域和市場成長策略的分析。

可以自訂此報告（需要額外的成本和時間表）。

  • 監管指引
  • 根據客戶興趣加入公司簡介
  • 按國家或地區進行的附加分析 – 市場規模和預測
  • 公司簡介的擴充列表
  • 歷史市場資料
  • 主要企業詳細資料（Excel 格式，包括位置、聯絡資訊、供應商/供應商網路等）

目錄

第1章 簡介

第 2 章執行摘要

第3章市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章腸溶軟膠囊市場：依應用分類

  • 概述
  • 保健補充品
  • 藥品

第5章腸溶軟膠囊市場：依分銷管道

  • 概述
  • 超級市場和大賣場
  • 藥局/藥局
  • 線上提供者

第6章腸溶軟膠囊市場：依地區

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 拉丁美洲
    • 巴西
    • 哥倫比亞
    • 阿根廷
    • 其他拉丁美洲
  • 中東/非洲
    • Gcc
    • 南非
    • 北非
    • 其他

第7章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 2022年主要企業定位

第8章 公司簡介

  • Catalent, Inc.
  • sirio pharma co., ltd.
  • Fuji Capsules Co. Ltd.
  • InovoBiologic Inc
  • NOW Foods Inc.
  • Gelita AG.
  • Captek Softgel International Inc.
  • Viva Pharmaceuticals
  • aenova group
  • Procaps Group
Product Code: A02601
Enteric Softgel Capsules Market - IMG1

The growth of the enteric softgel capsules market is strongly driven by the surging adoption of nutraceutical supplements and the benefits associated with enteric-coated softgel capsules. With an escalating focus on health, the demand for nutritional supplements is on the rise, contributing to the robust expansion of the nutraceutical industry. Enteric softgel capsules, distinguished by their precisely tailored enteric coatings, emerge as a strategic solution for delivering delicate active ingredients, safeguarding them from the harsh acidic conditions of the stomach. This targeted release mechanism optimizes absorption in the intestine, thereby elevating the bioavailability of pharmaceuticals and nutrients.The adaptability of enteric softgel capsules to delicate formulations positions them as a preferred choice for manufacturers aiming to ensure the effective and efficient delivery of health-enhancing compounds.

In addition, the merits of enteric-coated softgel capsules extend to enhanced patient compliance, effectively reducing the incidence of gastrointestinal discomfort. The capacity to mitigate side effects fosters greater overall tolerability of supplements and medications, promoting consistent usage. Furthermore, the adaptability of enteric softgel capsules to a diverse array of formulations further propels their popularity across pharmaceutical and nutraceutical applications. The expanding nutraceutical sector and the inherent advantages of enteric-coated softgel capsules synergize seamlessly, reflecting market growth driven by the evolving preferences of health-conscious consumers seeking efficacious and well-tolerated health solutions.

The enteric softgel capsules market is segmented on the basis of application, distribution channel, and region. On the basis of application, the market is segmented into health supplements and pharmaceuticals. On the basis of distribution channel, the market is segmented supermarket & hypermarket, pharmacy & drug store, and online provider. Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LA (Brazil, Colombia, Argentina, and rest of LA) and MEA (GCC, South Africa, North Africa and rest of MEA).

The major key players that operate in the global enteric softgel capsules market are Catalent, Inc., Sirio Pharma Co., Ltd., Fuji Capsules Co. Ltd., InovoBiologic Inc, NOW Foods Inc., Gelita AG, CAPTEK Softgel International Inc., Viva Pharmaceutical., Aenova Group, Procaps Group. The key players have adopted product launch as the key strategy to expand their product portfolio.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the enteric softgel capsules market analysis from 2022 to 2032 to identify the prevailing enteric softgel capsules market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the enteric softgel capsules market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global enteric softgel capsules market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Application

  • Health Supplements
  • Pharmaceuticals

By Distribution Channel

  • Supermarket and Hypermarket
  • Pharmacy and Drug store
  • Online Provider

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Colombia
    • Argentina
    • Rest Of La
  • Middle East and Africa
    • Gcc
    • South Africa
    • North Africa
    • Rest Of Mea

Key Market Players:

    • Catalent, Inc.
    • sirio pharma co., ltd.
    • Fuji Capsules Co. Ltd.
    • InovoBiologic Inc
    • NOW Foods Inc.
    • Gelita AG.
    • Captek Softgel International Inc.
    • Viva Pharmaceuticals
    • aenova group
    • Procaps Group

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Health Supplements
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Pharmaceuticals
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Supermarket and Hypermarket
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Pharmacy and Drug store
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Online Provider
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: ENTERIC SOFTGEL CAPSULES MARKET, BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast By Region
  • 6.2. North America
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by Application
    • 6.2.3. Market size and forecast, by Distribution Channel
    • 6.2.4. Market size and forecast, by country
      • 6.2.4.1. U.S.
      • 6.2.4.1.1. Market size and forecast, by Application
      • 6.2.4.1.2. Market size and forecast, by Distribution Channel
      • 6.2.4.2. Canada
      • 6.2.4.2.1. Market size and forecast, by Application
      • 6.2.4.2.2. Market size and forecast, by Distribution Channel
      • 6.2.4.3. Mexico
      • 6.2.4.3.1. Market size and forecast, by Application
      • 6.2.4.3.2. Market size and forecast, by Distribution Channel
  • 6.3. Europe
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by Application
    • 6.3.3. Market size and forecast, by Distribution Channel
    • 6.3.4. Market size and forecast, by country
      • 6.3.4.1. Germany
      • 6.3.4.1.1. Market size and forecast, by Application
      • 6.3.4.1.2. Market size and forecast, by Distribution Channel
      • 6.3.4.2. France
      • 6.3.4.2.1. Market size and forecast, by Application
      • 6.3.4.2.2. Market size and forecast, by Distribution Channel
      • 6.3.4.3. UK
      • 6.3.4.3.1. Market size and forecast, by Application
      • 6.3.4.3.2. Market size and forecast, by Distribution Channel
      • 6.3.4.4. Italy
      • 6.3.4.4.1. Market size and forecast, by Application
      • 6.3.4.4.2. Market size and forecast, by Distribution Channel
      • 6.3.4.5. Spain
      • 6.3.4.5.1. Market size and forecast, by Application
      • 6.3.4.5.2. Market size and forecast, by Distribution Channel
      • 6.3.4.6. Rest of Europe
      • 6.3.4.6.1. Market size and forecast, by Application
      • 6.3.4.6.2. Market size and forecast, by Distribution Channel
  • 6.4. Asia-Pacific
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by Application
    • 6.4.3. Market size and forecast, by Distribution Channel
    • 6.4.4. Market size and forecast, by country
      • 6.4.4.1. Japan
      • 6.4.4.1.1. Market size and forecast, by Application
      • 6.4.4.1.2. Market size and forecast, by Distribution Channel
      • 6.4.4.2. China
      • 6.4.4.2.1. Market size and forecast, by Application
      • 6.4.4.2.2. Market size and forecast, by Distribution Channel
      • 6.4.4.3. India
      • 6.4.4.3.1. Market size and forecast, by Application
      • 6.4.4.3.2. Market size and forecast, by Distribution Channel
      • 6.4.4.4. Australia
      • 6.4.4.4.1. Market size and forecast, by Application
      • 6.4.4.4.2. Market size and forecast, by Distribution Channel
      • 6.4.4.5. South Korea
      • 6.4.4.5.1. Market size and forecast, by Application
      • 6.4.4.5.2. Market size and forecast, by Distribution Channel
      • 6.4.4.6. Rest of Asia-Pacific
      • 6.4.4.6.1. Market size and forecast, by Application
      • 6.4.4.6.2. Market size and forecast, by Distribution Channel
  • 6.5. Latin America
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by Application
    • 6.5.3. Market size and forecast, by Distribution Channel
    • 6.5.4. Market size and forecast, by country
      • 6.5.4.1. Brazil
      • 6.5.4.1.1. Market size and forecast, by Application
      • 6.5.4.1.2. Market size and forecast, by Distribution Channel
      • 6.5.4.2. Colombia
      • 6.5.4.2.1. Market size and forecast, by Application
      • 6.5.4.2.2. Market size and forecast, by Distribution Channel
      • 6.5.4.3. Argentina
      • 6.5.4.3.1. Market size and forecast, by Application
      • 6.5.4.3.2. Market size and forecast, by Distribution Channel
      • 6.5.4.4. Rest Of La
      • 6.5.4.4.1. Market size and forecast, by Application
      • 6.5.4.4.2. Market size and forecast, by Distribution Channel
  • 6.6. Middle East and Africa
    • 6.6.1. Key market trends, growth factors and opportunities
    • 6.6.2. Market size and forecast, by Application
    • 6.6.3. Market size and forecast, by Distribution Channel
    • 6.6.4. Market size and forecast, by country
      • 6.6.4.1. Gcc
      • 6.6.4.1.1. Market size and forecast, by Application
      • 6.6.4.1.2. Market size and forecast, by Distribution Channel
      • 6.6.4.2. South Africa
      • 6.6.4.2.1. Market size and forecast, by Application
      • 6.6.4.2.2. Market size and forecast, by Distribution Channel
      • 6.6.4.3. North Africa
      • 6.6.4.3.1. Market size and forecast, by Application
      • 6.6.4.3.2. Market size and forecast, by Distribution Channel
      • 6.6.4.4. Rest Of Mea
      • 6.6.4.4.1. Market size and forecast, by Application
      • 6.6.4.4.2. Market size and forecast, by Distribution Channel

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product mapping of top 10 player
  • 7.4. Competitive dashboard
  • 7.5. Competitive heatmap
  • 7.6. Top player positioning, 2022

CHAPTER 8: COMPANY PROFILES

  • 8.1. Catalent, Inc.
    • 8.1.1. Company overview
    • 8.1.2. Key executives
    • 8.1.3. Company snapshot
    • 8.1.4. Operating business segments
    • 8.1.5. Product portfolio
    • 8.1.6. Business performance
    • 8.1.7. Key strategic moves and developments
  • 8.2. sirio pharma co., ltd.
    • 8.2.1. Company overview
    • 8.2.2. Key executives
    • 8.2.3. Company snapshot
    • 8.2.4. Operating business segments
    • 8.2.5. Product portfolio
    • 8.2.6. Business performance
    • 8.2.7. Key strategic moves and developments
  • 8.3. Fuji Capsules Co. Ltd.
    • 8.3.1. Company overview
    • 8.3.2. Key executives
    • 8.3.3. Company snapshot
    • 8.3.4. Operating business segments
    • 8.3.5. Product portfolio
    • 8.3.6. Business performance
    • 8.3.7. Key strategic moves and developments
  • 8.4. InovoBiologic Inc
    • 8.4.1. Company overview
    • 8.4.2. Key executives
    • 8.4.3. Company snapshot
    • 8.4.4. Operating business segments
    • 8.4.5. Product portfolio
    • 8.4.6. Business performance
    • 8.4.7. Key strategic moves and developments
  • 8.5. NOW Foods Inc.
    • 8.5.1. Company overview
    • 8.5.2. Key executives
    • 8.5.3. Company snapshot
    • 8.5.4. Operating business segments
    • 8.5.5. Product portfolio
    • 8.5.6. Business performance
    • 8.5.7. Key strategic moves and developments
  • 8.6. Gelita AG.
    • 8.6.1. Company overview
    • 8.6.2. Key executives
    • 8.6.3. Company snapshot
    • 8.6.4. Operating business segments
    • 8.6.5. Product portfolio
    • 8.6.6. Business performance
    • 8.6.7. Key strategic moves and developments
  • 8.7. Captek Softgel International Inc.
    • 8.7.1. Company overview
    • 8.7.2. Key executives
    • 8.7.3. Company snapshot
    • 8.7.4. Operating business segments
    • 8.7.5. Product portfolio
    • 8.7.6. Business performance
    • 8.7.7. Key strategic moves and developments
  • 8.8. Viva Pharmaceuticals
    • 8.8.1. Company overview
    • 8.8.2. Key executives
    • 8.8.3. Company snapshot
    • 8.8.4. Operating business segments
    • 8.8.5. Product portfolio
    • 8.8.6. Business performance
    • 8.8.7. Key strategic moves and developments
  • 8.9. aenova group
    • 8.9.1. Company overview
    • 8.9.2. Key executives
    • 8.9.3. Company snapshot
    • 8.9.4. Operating business segments
    • 8.9.5. Product portfolio
    • 8.9.6. Business performance
    • 8.9.7. Key strategic moves and developments
  • 8.10. Procaps Group
    • 8.10.1. Company overview
    • 8.10.2. Key executives
    • 8.10.3. Company snapshot
    • 8.10.4. Operating business segments
    • 8.10.5. Product portfolio
    • 8.10.6. Business performance
    • 8.10.7. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 02. ENTERIC SOFTGEL CAPSULES MARKET FOR HEALTH SUPPLEMENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. ENTERIC SOFTGEL CAPSULES MARKET FOR PHARMACEUTICALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. GLOBAL ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 05. ENTERIC SOFTGEL CAPSULES MARKET FOR SUPERMARKET AND HYPERMARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. ENTERIC SOFTGEL CAPSULES MARKET FOR PHARMACY AND DRUG STORE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. ENTERIC SOFTGEL CAPSULES MARKET FOR ONLINE PROVIDER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. ENTERIC SOFTGEL CAPSULES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. NORTH AMERICA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 10. NORTH AMERICA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 11. NORTH AMERICA ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 12. U.S. ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 13. U.S. ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 14. CANADA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 15. CANADA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 16. MEXICO ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 17. MEXICO ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 18. EUROPE ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 19. EUROPE ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 20. EUROPE ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 21. GERMANY ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 22. GERMANY ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 23. FRANCE ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 24. FRANCE ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 25. UK ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 26. UK ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 27. ITALY ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 28. ITALY ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 29. SPAIN ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 30. SPAIN ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 31. REST OF EUROPE ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 32. REST OF EUROPE ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 33. ASIA-PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 34. ASIA-PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 35. ASIA-PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 36. JAPAN ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 37. JAPAN ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 38. CHINA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 39. CHINA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 40. INDIA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 41. INDIA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 42. AUSTRALIA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 43. AUSTRALIA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 44. SOUTH KOREA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 45. SOUTH KOREA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 46. REST OF ASIA-PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 47. REST OF ASIA-PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 48. LATIN AMERICA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 49. LATIN AMERICA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 50. LATIN AMERICA ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 51. BRAZIL ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 52. BRAZIL ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 53. COLOMBIA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 54. COLOMBIA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 55. ARGENTINA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 56. ARGENTINA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 57. REST OF LA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 58. REST OF LA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 59. MIDDLE EAST AND AFRICA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 60. MIDDLE EAST AND AFRICA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 61. MIDDLE EAST AND AFRICA ENTERIC SOFTGEL CAPSULES MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 62. GCC ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 63. GCC ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 64. SOUTH AFRICA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 65. SOUTH AFRICA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 66. NORTH AFRICA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 67. NORTH AFRICA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 68. REST OF MEA ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 69. REST OF MEA ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022-2032 ($MILLION)
  • TABLE 70. CATALENT, INC.: KEY EXECUTIVES
  • TABLE 71. CATALENT, INC.: COMPANY SNAPSHOT
  • TABLE 72. CATALENT, INC.: PRODUCT SEGMENTS
  • TABLE 73. CATALENT, INC.: SERVICE SEGMENTS
  • TABLE 74. CATALENT, INC.: PRODUCT PORTFOLIO
  • TABLE 75. CATALENT, INC.: KEY STRATERGIES
  • TABLE 76. SIRIO PHARMA CO., LTD.: KEY EXECUTIVES
  • TABLE 77. SIRIO PHARMA CO., LTD.: COMPANY SNAPSHOT
  • TABLE 78. SIRIO PHARMA CO., LTD.: PRODUCT SEGMENTS
  • TABLE 79. SIRIO PHARMA CO., LTD.: SERVICE SEGMENTS
  • TABLE 80. SIRIO PHARMA CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 81. SIRIO PHARMA CO., LTD.: KEY STRATERGIES
  • TABLE 82. FUJI CAPSULES CO. LTD.: KEY EXECUTIVES
  • TABLE 83. FUJI CAPSULES CO. LTD.: COMPANY SNAPSHOT
  • TABLE 84. FUJI CAPSULES CO. LTD.: PRODUCT SEGMENTS
  • TABLE 85. FUJI CAPSULES CO. LTD.: SERVICE SEGMENTS
  • TABLE 86. FUJI CAPSULES CO. LTD.: PRODUCT PORTFOLIO
  • TABLE 87. FUJI CAPSULES CO. LTD.: KEY STRATERGIES
  • TABLE 88. INOVOBIOLOGIC INC: KEY EXECUTIVES
  • TABLE 89. INOVOBIOLOGIC INC: COMPANY SNAPSHOT
  • TABLE 90. INOVOBIOLOGIC INC: PRODUCT SEGMENTS
  • TABLE 91. INOVOBIOLOGIC INC: SERVICE SEGMENTS
  • TABLE 92. INOVOBIOLOGIC INC: PRODUCT PORTFOLIO
  • TABLE 93. INOVOBIOLOGIC INC: KEY STRATERGIES
  • TABLE 94. NOW FOODS INC.: KEY EXECUTIVES
  • TABLE 95. NOW FOODS INC.: COMPANY SNAPSHOT
  • TABLE 96. NOW FOODS INC.: PRODUCT SEGMENTS
  • TABLE 97. NOW FOODS INC.: SERVICE SEGMENTS
  • TABLE 98. NOW FOODS INC.: PRODUCT PORTFOLIO
  • TABLE 99. NOW FOODS INC.: KEY STRATERGIES
  • TABLE 100. GELITA AG.: KEY EXECUTIVES
  • TABLE 101. GELITA AG.: COMPANY SNAPSHOT
  • TABLE 102. GELITA AG.: PRODUCT SEGMENTS
  • TABLE 103. GELITA AG.: SERVICE SEGMENTS
  • TABLE 104. GELITA AG.: PRODUCT PORTFOLIO
  • TABLE 105. GELITA AG.: KEY STRATERGIES
  • TABLE 106. CAPTEK SOFTGEL INTERNATIONAL INC.: KEY EXECUTIVES
  • TABLE 107. CAPTEK SOFTGEL INTERNATIONAL INC.: COMPANY SNAPSHOT
  • TABLE 108. CAPTEK SOFTGEL INTERNATIONAL INC.: PRODUCT SEGMENTS
  • TABLE 109. CAPTEK SOFTGEL INTERNATIONAL INC.: SERVICE SEGMENTS
  • TABLE 110. CAPTEK SOFTGEL INTERNATIONAL INC.: PRODUCT PORTFOLIO
  • TABLE 111. CAPTEK SOFTGEL INTERNATIONAL INC.: KEY STRATERGIES
  • TABLE 112. VIVA PHARMACEUTICALS: KEY EXECUTIVES
  • TABLE 113. VIVA PHARMACEUTICALS: COMPANY SNAPSHOT
  • TABLE 114. VIVA PHARMACEUTICALS: PRODUCT SEGMENTS
  • TABLE 115. VIVA PHARMACEUTICALS: SERVICE SEGMENTS
  • TABLE 116. VIVA PHARMACEUTICALS: PRODUCT PORTFOLIO
  • TABLE 117. VIVA PHARMACEUTICALS: KEY STRATERGIES
  • TABLE 118. AENOVA GROUP: KEY EXECUTIVES
  • TABLE 119. AENOVA GROUP: COMPANY SNAPSHOT
  • TABLE 120. AENOVA GROUP: PRODUCT SEGMENTS
  • TABLE 121. AENOVA GROUP: SERVICE SEGMENTS
  • TABLE 122. AENOVA GROUP: PRODUCT PORTFOLIO
  • TABLE 123. AENOVA GROUP: KEY STRATERGIES
  • TABLE 124. PROCAPS GROUP: KEY EXECUTIVES
  • TABLE 125. PROCAPS GROUP: COMPANY SNAPSHOT
  • TABLE 126. PROCAPS GROUP: PRODUCT SEGMENTS
  • TABLE 127. PROCAPS GROUP: SERVICE SEGMENTS
  • TABLE 128. PROCAPS GROUP: PRODUCT PORTFOLIO
  • TABLE 129. PROCAPS GROUP: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF ENTERIC SOFTGEL CAPSULES MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN ENTERIC SOFTGEL CAPSULES MARKET
  • FIGURE 04. TOP INVESTMENT POCKETS IN ENTERIC SOFTGEL CAPSULES MARKET (2023-2032)
  • FIGURE 05. BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. BARGAINING POWER OF BUYERS
  • FIGURE 07. THREAT OF SUBSTITUTION
  • FIGURE 08. THREAT OF SUBSTITUTION
  • FIGURE 09. COMPETITIVE RIVALRY
  • FIGURE 10. GLOBAL ENTERIC SOFTGEL CAPSULES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. ENTERIC SOFTGEL CAPSULES MARKET, BY APPLICATION, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ENTERIC SOFTGEL CAPSULES MARKET FOR HEALTH SUPPLEMENTS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ENTERIC SOFTGEL CAPSULES MARKET FOR PHARMACEUTICALS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. ENTERIC SOFTGEL CAPSULES MARKET, BY DISTRIBUTION CHANNEL, 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ENTERIC SOFTGEL CAPSULES MARKET FOR SUPERMARKET AND HYPERMARKET, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF ENTERIC SOFTGEL CAPSULES MARKET FOR PHARMACY AND DRUG STORE, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ENTERIC SOFTGEL CAPSULES MARKET FOR ONLINE PROVIDER, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. ENTERIC SOFTGEL CAPSULES MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 19. U.S. ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 20. CANADA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 21. MEXICO ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 22. GERMANY ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 23. FRANCE ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 24. UK ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 25. ITALY ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. SPAIN ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. REST OF EUROPE ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. JAPAN ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. CHINA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. INDIA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. AUSTRALIA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. SOUTH KOREA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. REST OF ASIA-PACIFIC ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. BRAZIL ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. COLOMBIA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. ARGENTINA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. REST OF LA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. GCC ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. SOUTH AFRICA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. NORTH AFRICA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. REST OF MEA ENTERIC SOFTGEL CAPSULES MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 45. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 46. COMPETITIVE DASHBOARD
  • FIGURE 47. COMPETITIVE HEATMAP: ENTERIC SOFTGEL CAPSULES MARKET
  • FIGURE 48. TOP PLAYER POSITIONING, 2022